Plus Therapeutics, Inc. (Nasdaq: PSTV) ('Plus” or the 'Company”), a healthcare company developing and commercializing ...

Scientists at the University of Warwick have developed a fully fibre-coupled terahertz (THz) imaging system that ...

Aims to improve quality of care for patients with Alzheimer's disease… Exploring adoption of Neurophet's key ...

Ibex Medical Analytics has signed a strategic partnership with HNL Lab Medicine to deploy clinical-grade AI for prostate ...

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM) ("PAVmed"), today ...

Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2025 Earnings Call Transcript March 26, 2026 Lucid Diagnostics Inc. misses on earnings expectations. Reported EPS is $-0.1 EPS, expectations were $-0.07.

Submitted GraftAssureDx™ for kidney transplant rejection testing for FDA review on Wednesday, March 25Welcomed second ...

Pacific Fusion has opened up its pulsed-power Demonstration System to external researchers to run experiments on its high-energy platform.

Neurophet partners with US-based Alzheimer's network on imaging AI. South Korean company Neurophet has signed a memorandum of ...

General Fusion Inc. (“General Fusion” or the “Company”), a leader in the global race to commercialize fusion energy, today announced a new peer-reviewed publication in the scientific journal Fusion ...

No matter the size or severity, wounds on human skin are difficult to monitor while they heal. Biopsies disrupt the wound ...

The center will offer urgent care, primary and specialty care, and diagnostic services.